Companies: 10,795·Total market cap: $144.5T
Catalent, Inc.

Catalent, Inc.

CTLTNYSEHealthcare
$63.48
+$0.00(+0.00%)
Market Cap$11.5B
P/E Ratio
52W High$63.5
52W Low$42.11

Catalent, Inc. (CTLT) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · CTLT · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2024-062023-062022-062021-062020-06
Revenue
Revenue$4.38B$4.28B$4.83B$4.00B$3.09B
Cost of Revenue$3.43B$3.22B$3.19B$2.65B$2.11B
Gross Profit$0.95B$1.06B$1.64B$1.35B$0.98B
Gross Margin %(computed)21.75%24.79%33.97%33.82%31.78%
Operating Expenses
R&D Expenses$0.00B$0.02B$0.02B$0.02B$0.06B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$1.70B$0.99B$0.89B$0.71B$0.58B
Operating Income($0.75B)($0.14B)$0.35B$0.35B$0.14B
Operating Margin %(computed)-17.10%-3.20%7.23%8.85%4.65%
Interest Income$0.00B$0.00B$0.12B$0.11B$0.13B
Interest Expense$0.25B$0.19B$0.12B$0.11B$0.13B
Income Before Tax($1.03B)($0.32B)$0.60B$0.71B$0.26B
Income Tax Expense$0.02B($0.08B)$0.09B$0.13B$0.04B
Net Income($1.04B)($0.23B)$0.50B$0.58B$0.17B
Net Margin %(computed)-23.81%-5.43%10.34%14.63%5.59%
Per Share & EBITDA
EPS (Basic)$-5.76$-1.28$2.74$3.15$1.15
Wtd Avg Shares0.18B0.18B0.18B0.17B0.15B
EBITDA($0.28B)$0.27B$1.08B$1.11B$0.64B
EBITDA Margin %(computed)-6.48%6.22%22.37%27.86%20.69%

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B

Explore more Catalent, Inc. data

About Catalent, Inc. (CTLT) Income Statement

Catalent, Inc. (CTLT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, CTLT reported revenue of $4.38B, gross profit of $0.95B (gross margin 21.75%), and net income of ($1.04B) — a net profit margin of -23.81%.

Frequently asked questions

CTLT · 4 questions

Catalent, Inc. (CTLT) reported revenue of $4.38B for 2024, up 2.5% year-over-year.

CTLT revenueCTLT salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09